Telemedicine in the Management of Type 2 Diabetes Mellitus.
Source: Wang, G., et al. 2017 - Pubmed ID: 28104096
Setting: China, Hospital
Study design:
RCT
Follow up: 6 months
Patient group:
Sample size:
Total: 212 (178)
IG: 106 ( 93)
CG: 106 ( 85)
Inclusion criteria:
- Type 2 diabetes.
- HbA1c 7-10.0%
Type of technology:
Home monitoring
- Glucometer
Webpage
- Datatransfer
- Messaging
Phone
- Messaging
Intervention:
Intervention: Patients upload data to website 2 times a day, 2-3 days/week. Medical team log on to the website every 2 week to analyse data and to deliver advice to the patient leaving messages on the website or via telephone.
Duration: 6 months
Add on: NA
Control group: Usual care
Clinical effect:
- HbA1c ↓
- Plasma glucose ↓
Patient safety:
- No severe hypoglycemic event was reported during the study.
Patient experiences/
Staff experiences:
Patient experiences:
- Satisfaction score: 3.3-3.9/5.
- 80% patients in IG had been compliant with blood glucose monitoring 2-3 days/week, compliance rate was 72%.
Staff experiences: NA
Investment:
Equipment/Materials
- Blood glucose ,monitor
Staff resources
- Development of website
Running:
Staff resources
- Data monitoring and messaging
Organization: NA
Health care utilization: NA